Glenmark Pharmaceuticals informs about media release

24 Mar 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached a media release on 24th March 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity’ which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1023.90 -18.80 (-1.80%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.